Martha Marquesen

1.2k total citations
8 papers, 426 citations indexed

About

Martha Marquesen is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Martha Marquesen has authored 8 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Martha Marquesen's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Blood disorders and treatments (2 papers) and Chemokine receptors and signaling (2 papers). Martha Marquesen is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Blood disorders and treatments (2 papers) and Chemokine receptors and signaling (2 papers). Martha Marquesen collaborates with scholars based in United States, Cuba and Israel. Martha Marquesen's co-authors include Harry L. Malech, Dianne Hilligoss, Suk See De Ravin, Maria L. Turner, Edward W. Cowen, James E. Balow, Nora Naumann, Karyl S. Barron, John I. Gallin and Julia C. Friend and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Martha Marquesen

8 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martha Marquesen United States	5	307	120	83	72	66	8	426
Ehssan Sharif‐Askari Canada	10	398 1.3×	74 0.6×	61 0.7×	159 2.2×	26 0.4×	13	522
Katarzyna M. Luda Denmark	7	380 1.2×	73 0.6×	41 0.5×	90 1.3×	38 0.6×	10	514
Tessa A. M. Steevels Netherlands	11	248 0.8×	37 0.3×	65 0.8×	146 2.0×	30 0.5×	11	438
Felix Rosebrock Austria	5	254 0.8×	157 1.3×	38 0.5×	156 2.2×	52 0.8×	5	429
R Bonifer Germany	8	193 0.6×	80 0.7×	131 1.6×	96 1.3×	25 0.4×	10	386
A M Kruisbeek United States	17	750 2.4×	131 1.1×	69 0.8×	120 1.7×	43 0.7×	26	903
Hamlata Dewchand United Kingdom	12	313 1.0×	79 0.7×	88 1.1×	153 2.1×	54 0.8×	14	544
Liliana Clemenza Canada	9	291 0.9×	66 0.6×	24 0.3×	87 1.2×	40 0.6×	12	409
Kerri R. Thomas United States	6	587 1.9×	140 1.2×	44 0.5×	104 1.4×	25 0.4×	10	688
Chiharu Kanegane Japan	9	316 1.0×	375 3.1×	29 0.3×	100 1.4×	43 0.7×	14	559

Countries citing papers authored by Martha Marquesen

Since Specialization

Citations

This map shows the geographic impact of Martha Marquesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Marquesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Marquesen more than expected).

Fields of papers citing papers by Martha Marquesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Marquesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Marquesen. The network helps show where Martha Marquesen may publish in the future.

Co-authorship network of co-authors of Martha Marquesen

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Marquesen. A scholar is included among the top collaborators of Martha Marquesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Marquesen. Martha Marquesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Kang, Elizabeth M., Mark Parta, Dianne Hilligoss, et al.. (2016). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients. Biology of Blood and Marrow Transplantation. 22(3). S327–S328. 1 indexed citations

McDermott, David H., Qian Liu, Jean Ulrick, et al.. (2011). The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood. 118(18). 4957–4962. 95 indexed citations

Ravin, Suk See De, Victoria Anderson, Yvonne R. Shea, et al.. (2011). Geosmithia argillacea: An Emerging Cause of Invasive Mycosis in Human Chronic Granulomatous Disease. Clinical Infectious Diseases. 52(6). e136–e143. 54 indexed citations

Kang, Elizabeth M., Corin Kelly, Dianne Hilligoss, et al.. (2011). A Novel Non Myeloablative Regimen for Related and Unrelated Allogeneic Transplantation of High Risk Patients With Chronic Granulomatous Disease (CGD). Biology of Blood and Marrow Transplantation. 17(2). S295–S295. 2 indexed citations

McDermott, David H., Joseph Lopez, Francis Deng, et al.. (2010). AMD3100 is a potent antagonist at CXCR4^R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. Journal of Cellular and Molecular Medicine. 15(10). 2071–2081. 52 indexed citations

McDermott, David H., Suk See De Ravin, Hyun Sik Jun, et al.. (2010). Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 116(15). 2793–2802. 62 indexed citations

Ravin, Suk See De, Nora Naumann, Edward W. Cowen, et al.. (2008). Chronic granulomatous disease as a risk factor for autoimmune disease. Journal of Allergy and Clinical Immunology. 122(6). 1097–1103. 159 indexed citations

Chakrabarti, Sakti, Yoshiyuki Takahashi, Ramaprasad Srinivasan, et al.. (2004). Durable Engraftment and Long-Term Survival Following Fludarabine-Based Nonmyeloablative Hematopoietic Cell Transplantation (HCT) in Patients with ATG-Refractory Severe Aplastic Anemia (SAA) and Other Nonmalignant Hematological Disorders.. Blood. 104(11). 252–252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact